𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of relapsed or refractory adult acute lymphocytic leukemia

✍ Scribed by Mathias Freund; Helmut Diedrich; Arnold Gamer; Martin Gramatzki; Gerhard Heil; Axel Heyll; Michael Henke; Wolfgang Hiddemann; Rainer Haas; Rolf Kuse; Peter Koch; Hartmut Link; Georg Maschmeyer; Manfred Plonker; Wolfgang Queißier; Claire Schadeck-Gressel; Norbert Schmitz; Ulla Von Verschuer; Sibylla Wilhelm; Eckhard Thiel; Dieter Hoelzer

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
645 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine and cytosine arabinoside in
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia
✍ Samer Suki; Hagop Kantarjian; Varsha Gandhi; Elihu Estey; Susan O'Brien; Milosla 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Background: The objectives of the study were to evaluate the antileukemic efficacy and toxicity profiles of the combination of fludarabine and intermediate-dose cytosine arabinoside (ara-c) in refractory or relapsed adult acute lymphocytic leukemia (all). patients and methods. thirty adults with

Mitoxantrone in relapsed or refractory a
Mitoxantrone in relapsed or refractory acute nonlymphocytic leukemia
✍ Vredenburgh, James J. ;McLntyre, O. Ross ;Cornwell, Gibbons G. ;Ball, Edward D. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Seventeen patients with relapsed or refractory acute nonlymphocytic leukemia were treated with 14 mg/m2 of mitoxantrone given in a 30-minute infusion daily for three days. If the day fourteen bone marrow showed residual leukemia, a second course was given at the same dose for two days. Eight patient

Primary refractory and relapsed adult ac
Primary refractory and relapsed adult acute lymphoblastic leukemia : Characteristics, treatment results, and prognosis with salvage therapy
✍ Deborah A. Thomas; Hagop Kantarjian; Terry L. Smith; Charles Koller; Jorge Corte 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## BACKGROUND. Relapses continue to be problematic for adults with acute lymphoblastic leukemia (ALL). New therapies generally are first tested in the salvage setting prior to incorporation into frontline regimens. Defining the prognosis at relapse (or at failure of induction) and subsequently pre

Impact of reinduction regimens for relap
Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults
✍ Dr. Jeanna L. Welborn 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 2 views

## Abstract The clinical outlook for adults with acute lymphoblastic leukemia (ALL) has Improved with the use of intensive chemotherapy. Complete remissions (CR) are achieved in 80% of adults but the majority relapse on maintenance chemotherapy and a few exhibit primary resistance to induction ther